Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8316892 | Clinical Biochemistry | 2018 | 30 Pages |
Abstract
cTnI-II is the only FDA-cleared assay that has demonstrated high-sensitivity cTn assay. Use of recommended modeling in >300 healthy subjects for determining sex-specific 99th-percentile CDVs did not show statistically significant differences except with the Robust modeling.
Keywords
FDACDVLOQcTnPOCNT-proBNPEGFRMyocardial infarctionUnited States Food and Drug AdministrationEuropean Society of CardiologyUnited States of AmericaUSACardiac troponinSex-specificlimit of blankhigh-sensitivityESC99th percentilecardiac troponin ILoblimit of detectionlimit of quantitationestimated glomerular filtration ratepoint-of-careHemoglobinUSB
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Robert H. Christenson, Kristin Mullins, Show-Hong Duh,